Under construction – not a live service
Sign in
Enrolling by invitationNo phase

Tests repeat laser treatment for high eye pressure from glaucoma

Follows adults with glaucoma or high eye pressure, repeating laser treatment if needed.

Plain-language title generated from the registry record
Registry title: Optimal Treatment Protocol for Selective Laser Trabeculoplasty - Repeat Trial

Key facts

Where
Skövde and Uddevalla, SwedenSee the 2 sites

Where in Sweden

  • Department of Ophthalmology, Skaraborg HospitalSkövde, SwedenNo longer taking part
  • Department of Ophthalmology, NU Hospital GroupUddevalla, SwedenNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Vastra Gotaland Region
Trial code
NCT05159960
Record updated
30 September 2025
Original description
Glaucoma is a common eye disease that can lead to blindness. The only known way to reduce the rate of disease progression is by reducing the pressure in the eye (the intraocular pressure, IOP). Selective laser trabeculoplasty (SLT) is an ophthalmic laser intervention with the purpose of reducing the IOP.Read full original descriptionShow less

Optimal Treatment Protocol for Selective Laser Trabeculoplasty - Repeat Trial

Glaucoma is a common eye disease that can lead to blindness. The only known way to reduce the rate of disease progression is by reducing the pressure in the eye (the intraocular pressure, IOP). Selective laser trabeculoplasty (SLT) is an ophthalmic laser intervention with the purpose of reducing the IOP.

SLT can be performed in different ways, with four of the treatment protocols being evaluated in the Optimal SLT (OSLT) trial.

SLT is a repeatable procedure, but scientific evidence is scarce regarding more than one repetition. In this trial, patients included in the OSLT trial will be invited to the extended trial (OSLT-R), for further follow-up and re-treatment with SLT, if needed.

Inclusion: Included in the OSLT trial; Followed up without the need for other treatment escalation than repeat SLT.

Exclusion: Unable to participate in follow up due to health conditions, strength or physical location.

ClinicalTrials.gov NCT05159960